Full recovery, including complete healing of the incision site and final scar maturation, may take several months
Early-phase clinical trial data, including results from a Phase 2 trial published in the New England Journal of Medicine in 2023, demonstrated mean weight loss of up to approximately 24% of baseline body weight at 48 weeks in adults with obesity who did not have type 2 diabetes
-MSH=alpha-melanocyte-stimulating hormone, LEPR=leptin receptor, MC4R=melanocortin-4 receptor, POMC= proopiomelanocortin References: 1
A Phase 2 trial evaluating doses as low as 1 mg demonstrated measurable improvements in HbA1c levels and body weight, with fewer gastrointestinal side effects compared to higher doses, suggesting that starting with microdoses may enhance tolerability
This underscores the necessity of continuous therapy to manage this chronic disease
Small clinic case series (knee pain): One frequently cited study involved 12 patients with knee osteoarthritis or injury who received BPC-157 injections into the knee joint